Profile image
Conjoint Associate Professor

Dr Phillip Read

Phone
+61 (0)2 9385 0900
E-mail
phillip.read@unsw.edu.au
Cheng Q; Valerio H; Cunningham EB; Shih STF; Silk D; Conway A; Treloar C; Murray C; Henderson C; Amin J; Read P; Dore GJ; Grebely J; Bath N; Milat A; Dunlop A; Holden J; Leadbeatter K; Day E; Habraken N; Dawson O; Degenhardt L; Scott C; Tillakeratne S; Marks P; Jayasinghe I; Martinez M; Reid H; Gleeson V; Van Dyk J; Mercade GE; Marshall AD; Obeid S; Wheeler A; Hooshyar SH; Catlett B; Verich A; Erratt A; Wheeler A; Ezard N; Reid D; Gorton C; Hayllar J; Lam T; Datta P; Wade A; Spruce S; Cock V; Cornwell M; Zohrab K; Christmass M; Connelly C; Cooper A; Montebello M; Cherry R; Dyer J; Arawal S; Press E; Horasak N; Lewis R; Carthew A; Morris D; Donohue K; Griffiths K; Lana JD; Shin S; Graf C; Hampson A; Qian S; Brown D; Lautier A; Curran C; Burns C; Raidu R; Stolzenhein K; Brabender W; Somes K; Abram N; Turne R; Larter S; Goodberg F; Luksza J; Hall M; Hazelwood S; Ismay C; McClurg B; Mincham C; Barlow K; Hoskins A; Salisbury K; Markham J; Talmet J; Dunn S; Mitchell A; McKinnon A; Smyth F; Snell L; Laing E; Clark M; Dorigo J, 2024, 'Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study', Value in Health, 27, pp. 216 - 225, http://dx.doi.org/10.1016/j.jval.2023.10.013
2024
Carrington N; Conway A; Grebely J; Starr M; Catlett B; Stevens A; Prain B; McGrath C; Causer L; Guy R; Holden J; Keen P; Kingsland M; Lu H; Power C; Read P; Murray C; McNulty A; Cunningham P, 2024, 'Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-08989-8
2024
Munari SC; Wilkinson AL; Asselin J; Owen L; Read P; Finlayson R; Martin S; Bell C; O’Connor CC; Carter A; Guy R; McNulty A; Varma R; Chow EPF; Fairley CK; Donovan B; Stoove M; Goller JL; Hocking J; Hellard ME; Aung HL; Dimech W; Apostolellis A; Cogle A; Quinn B; Bradley C; Coase D; Heath-Paynter D; Lewis D; Nolan D; Huddy E; Sanguineti E; Douglas F; Amin J; Davies J; Doumany J; Bastian L; Charleton M; Gunathilake M; Campbell M; Pony M; Alliance S; Roth N; Cunningham P; Rees T; Baillie G; Nguyen T; Polkinghorne V; Traeger M; Watson N, 2024, 'Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018–2022', Sexual Health, 21, http://dx.doi.org/10.1071/SH23178
2024
Lahra MM; Latham NH; Templeton DJ; Read P; Carmody C; Ryder N; Ellis SE; Madden EF; Parasuraman A; Wells J; Sheppeard V; Armstrong BH; Holland J; Pendle S; Sherry N; Leong L; Papanicolas L; Selvey CE; Van Hal SJ, 2024, 'Investigation and response to an outbreak of Neisseria meningitidis serogroup Y ST-1466 urogenital infections, Australia', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.20
2024
Levinsson A; Zolopa C; Vakili F; Udhesister S; Kronfli N; Maheu-Giroux M; Bruneau J; Valerio H; Bajis S; Read P; Martró E; Boucher L; Morris L; Grebely J; Artenie A; Stone J; Vickerman P; Larney S, 2024, 'Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis', eClinicalMedicine, 72, http://dx.doi.org/10.1016/j.eclinm.2024.102596
2024
Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB, 2024, 'Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study', Drug and Alcohol Review, 43, pp. 1019 - 1028, http://dx.doi.org/10.1111/dar.13828
2024
Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394
2024
Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J, 2024, 'Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104468
2024
Macfarlane S; Haigh F; Woodland L; Goodger B; Larkin M; Miller E; Parcsi L; Read P; Wood L, 2024, 'Critical Success Factors for Intersectoral Collaboration: Homelessness and COVID-19 – Case Studies and Learnings from an Australian City', International Journal of Integrated Care, 24, pp. 19, http://dx.doi.org/10.5334/ijic.7653
2024
Read P; Tang BZH; Silins E; Doab A; Cornelisse VJ; Gilliver R, 2024, 'Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia', Viruses, 16, pp. 957 - 957, http://dx.doi.org/10.3390/v16060957
2024
Dharan NJ; Jin F; Vaccher S; Bavinton B; Yeung B; Guy R; Carr A; Zablotska I; Amin J; Read P; Templeton DJ; Ooi C; Martin SJ; Ryder N; Smith DE; McNulty A; Brown K; Price K; Holden J; Grulich AE, 2023, 'Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)', Clinical Infectious Diseases, 76, pp. E622 - E628, http://dx.doi.org/10.1093/cid/ciac660
2023
Cheng Q; Cunningham EB; Shih S; Amin J; Bruneau J; Artenie AA; Powis J; Litwin AH; Cooper C; Dalgard O; Hellard M; Bruggmann P; Marks P; Lacombe K; Stedman C; Read P; Hajarizadeh B; Dunlop AJ; Conway B; Feld JJ; Dore GJ; Grebely J; Dore G; Crawford S; Swan T; Byrne J; Coordinating Centre—Amanda Erratt ML; Marks P; Shaw I; Siriragavan S; Quiene S; Petoumenos K; Schmid P; Castro E; Moriggia A; Daulouede JP; Fraser C; Feld J; Gane E; Matthews G; Kronborg I; Shaw D; Norton B; Thurnheer MC; Weltman M; Dillon J; Kessler S; Knapp C; Oprandi L; Messina P; Pantic M; Le Cam M; Maitre C; Andreassen J; Melkeraaen I; Tollefsen MM; Pagarigan H; Milne R; Mason K; Kaznowski D; Zou L; Bouchard R; Kotsoros B; Muir M; Milloy J; Oliver V; Noonan T; Sevehon A; Hazelwood S; Hall M; Hagenauer M; Liddle R; Ferguson C; Agyemang L; Patel H; Soloway I; Cerocchi O; Lacalamita M; Fragomeli V; Gilliver R; Lothian R; Cleary S; Johnston L; Middleton S; D'Amico R; McGovern B; Anderson J; Zhong Z; Keane F; Tatsch F; Brainard D; McHutchison J, 2023, 'Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs', Value in Health, 26, pp. 883 - 892, http://dx.doi.org/10.1016/j.jval.2022.12.016
2023
Grebely J; Gilliver R; McNaughton T; Conway A; Cunningham E; Henderson C; Hadlow B; Molloy K; Doab A; Tillakeratne S; Pepolim L; Harrod ME; Dore GJ; Read P, 2023, 'Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103982
2023
Jessica HB; Carson J; Scott M; Patricia C; Nelson R; Helen VG; Phillip R; Hanson J; Robert M; Matthews G; Dore GJ; Martinello M; Read P, 2023, 'Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C)', Journal of Viral Hepatitis, 30, pp. 386 - 396, http://dx.doi.org/10.1111/jvh.13803
2023
Carter A; McManus H; Ward JS; Vickers T; Asselin J; Baillie G; Chow EPF; Chen MY; Fairley CK; Bourne C; McNulty A; Read P; Heath K; Ryder N; McCloskey J; Carmody C; McCormack H; Alexander K; Casey D; Stoove M; Hellard ME; Donovan B; Guy RJ, 2023, 'Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011–2019', Medical Journal of Australia, 218, pp. 223 - 228, http://dx.doi.org/10.5694/mja2.51864
2023
Koopsen J; Matthews G; Rockstroh J; Applegate TL; Bhagani S; Rauch A; Grebely J; Sacks-Davis R; Ingiliz P; Boesecke C; Rebers S; Feld J; Bruneau J; Martinello M; Hellard M; Dore GJ; Schinkel J; van der Valk M; Adams T; Amjad S; Appelhans C; Becker B; Bouchard R; Braun D; Bruelisauer C; Calcagnile S; Carroll A; Cerocchi O; Chronister K; Cordes C; Dore G; Evans F; Fedele S; Ferguson C; Fraser C; Ganase B; Gane E; George V; Gerlach C; Gilleece Y; Gilliver R; Grube C; Gustafson J; Haas A; Hagenauer M; Harris M; Helder J; Hirter D; Hull M; Katz S; Kim A; Kotsoros B; Lacalamita M; Lindergard G; Lutz T; Macabodbod L; Manz M; Marks P; Messina P; Mohrmann K; Monnich C; Moon J; Moriggia A; Morris G; Morrish T; Nelson M; Oliver V; Patterson J; Peters M; Petoumenos K; Porretta H; Raymode P; Read P; Reece S; Saidi A; Sasadeusz J; Scherler P; Schröder R; Selfridge M; Sevehon A; Shaw D; Sulkowski M; Tamaddoni M; Thunder O; Thurnheer MC; Tu E; Ustianowski A; Witele E, 2023, 'Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis', The Lancet Microbe, 4, pp. e622 - e631, http://dx.doi.org/10.1016/S2666-5247(23)00108-8
2023
Hobday S; Valerio H; Combo T; Monaghan R; Scott C; Silk D; Murray C; Read P; Henderson C; Degenhardt L; Treloar C; Dore GJ; Grebely J; Martinello M, 2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723
2023
Lam M; Read P, 2023, 'Syphilis If you don't look for it, you'll miss it', Medicine Today, 24, pp. 38 - 42
2023
Cornelisse VJ; Heath-Paynter D; Delpech V; Read P; Apostolellis A; Medland NA; MacIntyre CR; Giola M; Kidd M, 2023, 'How Australia and Aotearoa New Zealand avoided large-scale mpox (formerly monkeypox) outbreaks in 2022–2023', Internal Medicine Journal, 53, pp. 1732 - 1738, http://dx.doi.org/10.1111/imj.16236
2023
Conway A; Stevens A; Murray C; Prain B; Power C; McNulty A; Carrington N; Lu H; Kingsland M; McGrath C; Read P; Starr M; Catlett B; Cunningham P; Grebely J, 2023, 'Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study', Open Forum Infectious Diseases, 10, http://dx.doi.org/10.1093/ofid/ofad517
2023
Grebely J; Markus C; Causer LM; Silk D; Comben S; Lloyd AR; Martinez M; Cunningham EB; O'Flynn M; Dore GJ; Matthews S, 2023, 'A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia', The Lancet Gastroenterology and Hepatology, 8, pp. 204 - 207, http://dx.doi.org/10.1016/S2468-1253(22)00355-7
2023
Amin J; Vaccher S; Templeton DJ; Bavinton B; Jin F; Zablotska I; Matthews G; Ogilvie E; Yeung B; Ooi C; Dharan N; Baker DA; Read P; Guy R; Grulich AE, 2022, 'Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus–Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings from the Expanded PrEP Implementation in Communities–New South Wales Prospective Implementation Study', Clinical Infectious Diseases, 75, pp. 1497 - 1502, http://dx.doi.org/10.1093/cid/ciac231
2022
Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555
2022
Conway A; Read P; Gilliver R; McNaughton T; Valerio H; Cunningham EB; Henderson C; Hadlow B; Molloy K; Doab A; Tillakeratne S; Pepolim L; Harrod ME; Dore GJ; Grebely J, 2022, 'Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study', Viruses, 14, http://dx.doi.org/10.3390/v14112463
2022
Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876
2022
Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; ETHOS Engage Study Group , 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.', Int J Drug Policy, 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706
2022
Bartlett SR; Verich A; Carson J; Hosseini-Hooshyar S; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Martinez M; Marks P; Dore GJ; Matthews GV; Applegate T; Martinello M; Hosseini Hooshyar S, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
2022
Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543
2022
Yee J; Carson JM; Hajarizadeh B; Hanson J; O’Beirne J; Iser D; Read P; Balcomb A; Doyle JS; Davies J; Martinello M; Marks P; Dore GJ; Matthews GV; Hanson J; Marks P; Byrne M; Post J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Davies J; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study', Hepatology Communications, 6, pp. 496 - 512, http://dx.doi.org/10.1002/hep4.1826
2022
Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Matthews GV; Dore GJ; Post J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Stewart J; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'Retreatment for hepatitis C virus direct-acting antiviral therapy virological failure in primary and tertiary settings: The REACH-C cohort', Journal of Viral Hepatitis, 29, pp. 661 - 676, http://dx.doi.org/10.1111/jvh.13705
2022
Monds LA; Bravo M; Mills L; Malcolm A; Gilliver R; Wood W; Harrod ME; Read P; Nielsen S; Dietze PM; Lenton S; Bleeker AM; Lintzeris N, 2022, 'The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions', Drug and Alcohol Review, 41, pp. 1085 - 1094, http://dx.doi.org/10.1111/dar.13474
2022
Gilliver R; Silins E; Read P, 2022, '‘Lifting the invisibility cloak’ on the pivotal role of nurses in hepatitis C (HCV) testing, diagnosis and management – findings from an integrated primary healthcare service for marginalised people in inner Sydney, Australia', Australian Journal of Advanced Nursing, 39, http://dx.doi.org/10.37464/2020.394.785
2022
Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6
2021
Cunningham EB; Hajarizadeh B; Amin J; Hellard M; Bruneau J; Feld JJ; Cooper C; Powis J; Litwin AH; Marks P; Dalgard O; Conway B; Moriggia A; Stedman C; Read P; Bruggmann P; Lacombe K; Dunlop A; Applegate TL; Matthews GV; Fraser C; Dore GJ; Grebely J, 2021, 'Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection among People Who Inject Drugs', Clinical Infectious Diseases, 72, pp. 1392 - 1400, http://dx.doi.org/10.1093/cid/ciaa253
2021
Patel PG; Keen P; McManus H; Duck T; Callander D; Selvey C; Power C; Gray RT; Knight V; Asselin J; Read P; Johnson K; Bavinton BR; Bowden VJ; Grulich AE; Guy R; Prestage G; Zablotska I; Holden J; Cooper C; Price K; Holt M; de Wit J; Kaldor J; Kelleher A; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Madeddu D; Schmidt HM; Telfer B; Price K; Boyd M; McGill S; Pinto A; Nigro S; Gordon T; Feeney L; Cunningham P; Mao L; Gray J; O’Dwyer M; Clifton B, 2021, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men', HIV Medicine, 22, pp. 605 - 616, http://dx.doi.org/10.1111/hiv.13102
2021
Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Dore GJ; Matthews GV, 2021, 'Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103422
2021
Grebely J; Tran L; Degenhardt L; Dowell-Day A; Santo T; Larney S; Hickman M; Vickerman P; French C; Butler K; Gibbs D; Valerio H; Read P; Dore GJ; Hajarizadeh B, 2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612
2021
Chan C; Patel P; Johnson K; Vaughan M; Price K; McNulty A; Templeton D; Read P; Cunningham P; Grulich A; Bavinton B, 2021, 'Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia', AIDS, 35, pp. 1878 - 1880, http://dx.doi.org/10.1097/QAD.0000000000002982
2021
Matthews GV; Bhagani S; Van der Valk M; Rockstroh J; Feld JJ; Rauch A; Thurnheer C; Bruneau J; Kim A; Hellard M; Shaw D; Gane E; Nelson M; Ingiliz P; Applegate TL; Grebely J; Marks P; Martinello M; Petoumenos K; Dore GJ; Marks P; Feld J; Amjad S; Tu E; Tamaddoni M; Thurnheer MC; Gilleece Y; Fraser C; Moriggia A; Lutz T; Moon J; Read P; Ustianowski A; Cordes C; Sasadeusz J; Hull M; Braun D, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056
2021
Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore G; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571
2021
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421
2021
Gibbs D; Price O; Grebely J; Larney S; Sutherland R; Read P; Butler K; Degenhardt L; Peacock A, 2021, 'Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109050
2021
Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Applegate T; Read P; Hajarizadeh B; Ezard N; Dore G; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
2020
Artenie AA; Cunningham EB; Dore GJ; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Lacombe K; Stedman C; Litwin AH; Marks P; Matthews GV; Quiene S; Erratt A; Bruneau J; Grebely J, 2020, 'Patterns of drug and alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis c virus treatment with directacting antiviral therapies: An international study', Clinical Infectious Diseases, 70, pp. 2369 - 2376, http://dx.doi.org/10.1093/cid/ciz633
2020
Grebely J; Read P; Cunningham EB; Weltman M; Matthews GV; Dunlop A; Montebello M; Martinello M; Gilliver R; Marks P; Applegate TL; Dore GJ, 2020, 'Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial', Health Science Reports, 3, http://dx.doi.org/10.1002/hsr2.151
2020
Cunningham EB; Hajarizadeh B; Amin J; Litwin AH; Gane E; Cooper C; Lacombe K; Hellard M; Read P; Powis J; Dalgard O; Bruneau J; Matthews GV; Feld JJ; Dillon JF; Shaw D; Bruggmann P; Conway B; Fraser C; Marks P; Dore GJ; Grebely J, 2020, 'Adherence to once-daily and twice-daily direct-acting antiviral therapy for Hepatitis C infection among people with recent injection drug use or current opioid agonist therapy', Clinical Infectious Diseases, 71, pp. E115 - E124, http://dx.doi.org/10.1093/cid/ciz1089
2020
Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A, 2020, 'Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives', Drug and Alcohol Review, 39, pp. 55 - 65, http://dx.doi.org/10.1111/dar.13015
2020
Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV, 2020, 'Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV', AIDS, 34, pp. 1347 - 1358, http://dx.doi.org/10.1097/QAD.0000000000002562
2020
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985
2020
Gilliver R; Kearley J; Read P, 2020, 'Preparing for a syndemic: incorporating opioid overdose management into routine care for people who inject drugs initiating hepatitis C treatment', Internal Medicine Journal, 50, pp. 382 - 383, http://dx.doi.org/10.1111/imj.14755
2020
Lazarus JV; Pericàs JM; Picchio C; Cernosa J; Hoekstra M; Luhmann N; Maticic M; Read P; Robinson EM; Dillon JF, 2019, 'We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade', Journal of Internal Medicine, 286, pp. 503 - 525, http://dx.doi.org/10.1111/joim.12972
2019
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112
2019
Read P; Gilliver R; Kearley J; Lothian R; Cunningham EB; Chronister KJ; Dore GJ, 2019, 'Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection', Journal of Viral Hepatitis, 26, pp. 1301 - 1310, http://dx.doi.org/10.1111/jvh.13175
2019
Chronister KJ; Lothian R; Gilliver R; Kearley J; Read P, 2019, 'Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low-threshold primary health-care opioid agonist treatment program', Drug and Alcohol Review, 38, pp. 185 - 189, http://dx.doi.org/10.1111/dar.12903
2019
Read P; Chronister KJ; Kostovski C; Harrod ME; Salmon A; Jauncey M, 2019, 'Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia', Sexual Health, 16, pp. 383 - 388, http://dx.doi.org/10.1071/SH18228
2019
Callander D; Cook T; Read P; Hellard ME; Fairley CK; Kaldor JM; Vlahakis E; Pollack A; Bourne C; Russell DB; Guy RJ; Donovan B, 2019, 'Sexually transmissible infections among transgender men and women attending Australian sexual health clinics', Medical Journal of Australia, 211, pp. 406 - 411, http://dx.doi.org/10.5694/mja2.50322
2019
Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9
2019
Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'SAT-232-Reinfection following successful HCV DAA therapy among people with recent injecting drug use', Journal of Hepatology, 70, pp. e732 - e733, http://dx.doi.org/10.1016/s0618-8278(19)31465-3
2019
Purcell T; Wade A; Accadia L; Strasser S; Read P; Allard N; Baker D; Pedrana A; Doyle J, 2019, 'Eliminating hepatitis C: Part 3. Curing hepatitis C in general practice', Medicine Today, 20, pp. 20 - 26
2019
Keen P; Jamil M; Callander D; Conway DP; McNulty A; Davies SC; Couldwell DC; Smith DE; Holt M; Vaccher SJ; Gray J; Cunningham P; Prestage G; Guy R; Read P; Varma R; O'Connor C, 2019, 'Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before–after study', Sexual Health, 16, pp. 172 - 179, http://dx.doi.org/10.1071/sh18161
2019
Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HMA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA; Smith D; Ooi C; Martin S; Soo TM; Templeton D; Townson D; Forssman B; Doong N; Han Thai G; Anderson B; MacLeod H; Parkhill N; Cooper D; Law M, 2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7
2018
Grebely J; Dalgard O; Conway B; Cunningham EB; Bruggmann P; Hajarizadeh B; Amin J; Bruneau J; Hellard M; Litwin AH; Marks P; Quiene S; Siriragavan S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Dillon JF; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial', The Lancet Gastroenterology and Hepatology, 3, pp. 153 - 161, http://dx.doi.org/10.1016/S2468-1253(17)30404-1
2018
Cunningham EB; Amin J; Feld JJ; Bruneau J; Dalgard O; Powis J; Hellard M; Cooper C; Read P; Conway B; Dunlop AJ; Norton B; Litwin AH; Hajarizadeh B; Thurnheer MC; Dillon JF; Weltman M; Shaw D; Bruggmann P; Gane E; Fraser C; Marks P; Applegate TL; Quiene S; Siriragavan S; Matthews GV; Dore GJ; Grebely J, 2018, 'Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study', International Journal of Drug Policy, 62, pp. 14 - 23, http://dx.doi.org/10.1016/j.drugpo.2018.08.013
2018
Templeton DJ; Adam PCG; Varma R; Read P; Bourne C; Kao SC, 2018, 'Evaluation of knowledge and utility of the 2014 Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men among general practitioners in Sydney', Sexual Health, 15, pp. 96 - 98, http://dx.doi.org/10.1071/SH17113
2018
Keen P; Conway DP; Cunningham P; McNulty A; Couldwell DL; Davies SC; Smith DE; Gray J; Holt M; O'Connor CC; Read P; Callander D; Prestage G; Guy R, 2017, 'Multi-centre field evaluation of the performance of the Trinity Biotech Uni-Gold HIV 1/2 rapid test as a first-line screening assay for gay and bisexual men compared with 4th generation laboratory immunoassays', Journal of Clinical Virology, 86, pp. 46 - 51, http://dx.doi.org/10.1016/j.jcv.2016.11.006
2017
Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I, 2017, 'Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting', International Journal of Drug Policy, 47, pp. 209 - 215, http://dx.doi.org/10.1016/j.drugpo.2017.05.032
2017
Chow EPF; Callander D; Fairley CK; Zhang L; Donovan B; Guy R; Lewis DA; Hellard M; Read P; Ward A; Chen MY; Kaldor J; Grulich A; Marshall L; O'Connor C; Wilson D; Dickson B; Ali H; Smith LW; Jackson E; Russell D; Vhalkis E; Gunathilake M; Nikitas A; O'Sullivan M; Allen D; Ryder N; Brown K; Smith D; Paramsothy Y; Palmer C; Davies S; McNulty A; Menon A; Parker A, 2017, 'Increased Syphilis Testing of Men Who Have Sex With Men: Greater Detection of Asymptomatic Early Syphilis and Relative Reduction in Secondary Syphilis', Clinical Infectious Diseases, 65, pp. 389 - 395, http://dx.doi.org/10.1093/cid/cix326
2017
Chronister KJ; Gilliver R; Kearley J; Lothian R; Dore GJ; Read P, 2017, 'P54 Treatment adherence among people who inject drugs taking directly observed direct acting antiviral therapy at Kirketon Road Centre', Journal of Virus Eradication, 3, pp. 30 - 30, http://dx.doi.org/10.1016/s2055-6640(20)30795-0
2017
Chronister KJ; Lothian R; Kearley J; Gilliver R; Read P, 2017, 'P55 Client acceptability and feasibility of expanded access to direct acting antiviral therapy for hepatitis at the Kirketon Road Centre', Journal of Virus Eradication, 3, pp. 31 - 31, http://dx.doi.org/10.1016/s2055-6640(20)30796-2
2017
Gilliver R; Machin W; Kearley J; Lothian R; Chronister KJ; Read P, 2017, 'O10 Treatment of Aboriginal and Torres Strait Islander clients with direct acting antivirals at the Kirketon Road Centre', Journal of Virus Eradication, 3, pp. 4 - 4, http://dx.doi.org/10.1016/s2055-6640(20)30893-1
2017
Read P, 2017, 'Everything old is new again: Don't forget about syphilis', Medicine Today, 18, pp. 49 - 52
2017
Foster R; Ali H; Crowley M; Dyer R; Grant K; Lenton J; Little C; Knight V; Read P; Donovan B; McNulty A; Guy R, 2016, 'Does Living Outside of a Major City Impact on the Timeliness of Chlamydia Treatment? A Multicenter Cross-Sectional Analysis', Sexually Transmitted Diseases, 43, pp. 506 - 512, http://dx.doi.org/10.1097/OLQ.0000000000000496
2016
Read P; Tagg KA; Jeoffreys N; Guy RJ; Gilbert GL; Donovan B, 2016, 'Treponema pallidum strain types and association with macrolide resistance in Sydney, Australia: New TP0548 gene types identified', Journal of Clinical Microbiology, 54, pp. 2172 - 2174, http://dx.doi.org/10.1128/JCM.00959-16
2016
Smith KS; Kaldor JM; Hocking JS; Jamil MS; McNulty AM; Read P; Bradshaw CS; Chen MY; Fairley CK; Wand H; Worthington K; Blake S; Knight V; Rawlinson W; Saville M; Tabrizi SN; Garland SM; Donovan B; Guy R, 2016, 'The acceptability and cost of a home-based chlamydia retesting strategy: Findings from the REACT randomised controlled trial', BMC Public Health, 16, pp. 83, http://dx.doi.org/10.1186/s12889-016-2727-4
2016
Callander DJ; Read P; Prestage G; Minichiello V; Chow EPF; Lewis DA; McNulty A; Ali H; Hellard M; Guy R; Donovan B, 2016, 'A cross-sectional study of HIV and STIs among male sex workers attending Australian sexual health clinics', Sexually Transmitted Infections, Published Online First 2 September 2016, pp. 299 - 302, http://dx.doi.org/10.1136/sextrans-2016-052578
2016
Read PJ; Guy R; Jeoffreys N; Baker D; Shields M; Donovan B, 2015, 'Treatment and outcomes of polymerase chain reaction-confirmed early syphilis', Sexual Health, 12, pp. 506 - 511, http://dx.doi.org/10.1071/SH15043
2015
Smith KS; Hocking JS; Chen MY; Fairley CK; McNulty AM; Read P; Bradshaw CS; Tabrizi SN; Wand H; Saville M; Rawlinson W; Garland SM; Donovan B; Kaldor JM; Guy RJ, 2015, 'Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three Populations', American Journal of Preventive Medicine, 49, pp. 1 - 11, http://dx.doi.org/10.1016/j.amepre.2015.01.014
2015
Chan D; Stewart M; Smith M; Price T; Lusk J; Ooi C; Read P; Finlayson R, 2015, 'The rise of targeted HIV oral rapid testing in Australia', Medical Journal of Australia, 202, pp. 251 - 254, http://dx.doi.org/10.5694/mja14.01292
2015
Read P; Fairley CK; Chow EPF, 2015, 'Increasing trends of syphilis among men who have sex with men in high income countries', Sexual Health, 12, pp. 155 - 163, http://dx.doi.org/10.1071/SH14153
2015
Marshall AD; Micallef M; Erratt A; Telenta J; Treloar C; Everingham H; Jones SC; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop A; Jauncey M; Read P; Collie T; Dore GJ; Grebely J, 2015, 'Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study', International Journal of Drug Policy, 26, pp. 984 - 991, http://dx.doi.org/10.1016/j.drugpo.2015.07.002
2015
Read P; Jeoffreys N; Tagg K; Guy RJ; Gilbert GL; Donovan B, 2014, 'Azithromycin-resistant syphilis-causing strains in Sydney, Australia: Prevalence and risk factors', Journal of Clinical Microbiology, 52, pp. 2776 - 2781, http://dx.doi.org/10.1128/JCM.00301-14
2014
Smith KS; Hocking JS; Chen M; Fairley CK; McNulty A; Read P; Bradshaw CS; Tabrizi SN; Wand H; Saville M; Rawlinson W; Garland SM; Donovan B; Kaldor JM; Guy R, 2014, 'Rationale and design of REACT: A randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests', BMC Infectious Diseases, 14, pp. 223, http://dx.doi.org/10.1186/1471-2334-14-223
2014
Mcallister J; Read P; Mcnulty A; Tong W; Ingersoll A; Carr A, 2014, 'Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: Safety, tolerability and adherence', HIV Medicine, 15, pp. 13 - 22, http://dx.doi.org/10.1111/hiv.12075
2014
Templeton DJ; Read P; Varma R; Bourne C, 2014, 'Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: A review of the evidence', Sexual Health, 11, pp. 217 - 229, http://dx.doi.org/10.1071/SH14003
2014
Mulhall BP; Wright S; Allen D; Brown K; Dickson B; Grotowski M; Jackson E; Petoumenos K; Read P; Read T; Russell D; Smith DJ; Templeton DJ; Fairley CK; Law MG; Han A, 2014, 'High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: A prospective cohort study', Sexual Health, 11, pp. 291 - 297, http://dx.doi.org/10.1071/SH13074
2014
Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM, 2013, 'One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia', Sexual Health, 10, pp. 460 - 462, http://dx.doi.org/10.1071/SH13077
2013
Kwon I; Mcnulty A; Read P, 2013, 'The prevalence of Trichomonas vaginalis detected by wet mount and polymerase chain reaction in Sydney women', Sexual Health, 10, pp. 385 - 386, http://dx.doi.org/10.1071/SH12201
2013
McCann L; Allan W; Read P; McNulty A, 2013, 'Contact tracing using provider referral: How difficult is it?', Sexual Health, 10, pp. 472 - 473, http://dx.doi.org/10.1071/SH13085
2013
Smith KS; Hocking JS; Wand H; Chen M; Fairley CK; Bradshaw CS; Read P; McNulty A; Saville M; Tabrizi N, 2013, 'HOME-BASED SAMPLE COLLECTION INCREASES CHLAMYDIA RETESTING AND DETECTS ADDITIONAL REPEAT POSITIVE TESTS: A RANDOMISED CONTROLLED TRIAL IN THREE RISK GROUPS', SEXUALLY TRANSMITTED INFECTIONS, 89, pp. A70 - A71, http://dx.doi.org/10.1136/sextrans-2013-051184.0215
2013
Read PJ; McNulty A, 2013, 'Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome', Medical Journal of Australia, 199, pp. 27 - 28, http://dx.doi.org/10.5694/mja13.10194
2013
Read PJ; Knight V; Bourne C; Guy R; Donovan B; Allan W; Mcnulty AM, 2013, 'Community event-based outreach screening for syphilis and other sexually transmissible infections among gay men in Sydney, Australia', Sexual Health, 10, pp. 357 - 362, http://dx.doi.org/10.1071/SH13012
2013
Martin L; Knight V; Read PJ; Mcnulty A, 2013, 'Fast-track services for all? The preferences of Chinese-, Korean-, and Thai-speaking women attending a sexual health service', Sexually Transmitted Diseases, 40, pp. 929 - 932, http://dx.doi.org/10.1097/OLQ.0000000000000055
2013
Ewing M; Read P; Knight V; Morgan S; Hanlon M; McDonald A; Mclver R; Wright S; McNulty A, 2013, 'Do callers to the NSW Sexual Health Infoline attend the services they are referred to?', Sexual Health, 10, pp. 530 - 532, http://dx.doi.org/10.1071/SH13106
2013
Martin L; Knight V; Read PJ; McNulty A, 2013, 'Clients' preferred methods of obtaining sexually transmissible infection or HIV results from Sydney Sexual Health Centre', Sexual Health, 10, pp. 91 - 92, http://dx.doi.org/10.1071/SH12062
2013
Read PJ; Lucas S; Morris S; Kulasegaram R, 2013, 'Immune reconstitution inflammatory syndrome Kaposi sarcoma in the liver manifesting as acute obstructive hepatitis: Another potential role for montelukast?', International Journal of STD and AIDS, 24, pp. 156 - 158, http://dx.doi.org/10.1177/0956462412472819
2013
Read PJ; Mandalia S; Khan P; Harrisson U; Naftalin C; Gilleece Y; Anderson J; Hawkins D; Taylor G; De ruiter A; De Ruiter A, 2012, 'When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?', AIDS, 26, pp. 1095 - 1103, http://dx.doi.org/10.1097/QAD.0b013e3283536a6c
2012
Read PJ; Wand HC; Guy R; Donovan B; McNulty A, 2012, 'Unprotected fellatio between female sex workers and their clients in Sydney, Australia', Sexually Transmitted Infections, http://dx.doi.org/10.1136/sextrans-2011-050430
2012
Guy R; Wand HC; Knight V; Kenigsberg A; Read PJ; McNulty AM, 2012, 'SMS reminders improve re-screening in women and heterosexual men with chlamydia infection at Sydney Sexual Health Centre: a before-and-after study.', Sexually Transmitted Infections, http://dx.doi.org/10.1136/sextrans-2011-050370
2012
Read PJ; Donovan B, 2012, 'Clinical aspects of adult syphilis', Internal Medicine Journal, 42, pp. 614 - 620, http://dx.doi.org/10.1111/j.1445-5994.2012.02814.x
2012
McManus H; O'Connor CC; Boyd MA; Broom J; Russell D; Watson K; Roth N; Read PJ; Law M; Petoumenos K; Templeton D; Han A, 2012, 'Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy', PLoS One, 7, pp. Article numbere48839, http://dx.doi.org/10.1371/journal.pone.0048839
2012
Read PJ; Martin L; McNulty A, 2012, 'Would you self-collect swabs in a unisex toilet?', Sexual Health, 9, pp. 395 - 396, http://dx.doi.org/10.1071/SH12016
2012
Kwan B; Ryder N; Knight V; Kenigsberg A; McNulty A; Read PJ; Bourne CP, 2012, 'Sensitivity of 20-minute voiding intervals in men testing for chlamydia trachomatis', Sexually Transmitted Diseases, 39, pp. 405 - 406, http://dx.doi.org/10.1097/OLQ.0b013e318248a563
2012
Bateson D; Freedman E; Stewart M; Read P, 2012, 'The who, what and from where of STIs: Selective testing in asymptomatic patients', Medicine Today, 13, pp. 12 - 21
2012
Read P, 2012, 'Syphilis screening and treatment', Australian Family Physician, 41, pp. 920
2012
Guy R; Wand H; Read P; Kenigsberg A; Knight V; McNulty A, 2011, 'P5-S4.07 SMS reminders increase re-testing for repeat chlamydial infection in heterosexuals at a sexual health clinic', Sexually Transmitted Infections, 87, pp. A324.2 - A324, http://dx.doi.org/10.1136/sextrans-2011-050108.548
2011
Drummond F; Ryder N; Wand H; Guy R; Read P; McNulty A; Wray L; Donovan B, 2011, 'IS SINGLE DOSE AZITHROMYCIN ADEQUATE FOR ASYMPTOMATIC RECTAL CHLAMYDIA?', SEXUALLY TRANSMITTED INFECTIONS, 87, pp. A76 - A76, http://dx.doi.org/10.1136/sextrans-2011-050109.122
2011
Read P; Armstrong-James D; Tong CYW; Fox J, 2011, 'Missed opportunities for HIV testing-a costly oversight', QJM: An International Journal of Medicine, 104, pp. 421 - 424, http://dx.doi.org/10.1093/qjmed/hcq236
2011
Lockwood T; Knight V; Hanlon M; Bourne C; Read P, 2011, 'Contact tracing impact on bacterial STI re-infection?', Australian nursing journal (July 1993), 19, pp. 36 - 37
2011
Read PJ; Fox J, 2010, 'Infectious syphilis unmasking drug resistance in an individual with long-term virological suppression on antiretroviral therapy', Sexually Transmitted Infections, 86, pp. 276 - 277, http://dx.doi.org/10.1136/sti.2010.043364
2010
Tapsall JW; Read P; Carmody CJ; Bourne CP; Ray S; Limnios A; Sloots T; Whiley D, 2009, 'Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods', Journal of Medical Microbiology, 58, pp. 683 - 687, http://dx.doi.org/10.1099/jmm.0.007641-0
2009
Read P; Abbott R; Pantelidis P; Peters BS; White JA, 2008, 'Disseminated gonococcal infection in a homosexual man diagnosed by nucleic acid amplification testing from a skin lesion swab', Sexually Transmitted Infections, 84, pp. 348 - 349, http://dx.doi.org/10.1136/sti.2008.030817
2008
Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; Taylor GP; De Ruiter A, 2008, 'New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines', HIV Medicine, 9, pp. 448 - 451, http://dx.doi.org/10.1111/j.1468-1293.2008.00594.x
2008
Taylor A; Wilson D; Read P, 1993, 'Prevalence of hearing loss.', Australian journal of public health, 17, pp. 77
1993
Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J, 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', in International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2022.103706
2022
Molloy K; Cho L; Silins E; Read P, 2022, 'Providing unplanned pregnancy care and Early Medical Abortion to marginalised groups at the Kirketon Road Centre (KRC) - a walk in targeted primary health care service in Kings Cross, Sydney', Sydney, presented at Children by Choice, Sydney, 04 August 2022, http://dx.doi.org/10.1016/j.wombi.2022.07.010
2022
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Amin J; Christmass M; Dunlop AJ; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Dore GJ; Treloar C; Grebely J, 2021, 'OPIOID OVERDOSE AND NALOXONE ACCESS AMONG PEOPLE WHO RECENTLY USED OPIOIDS OR RECEIVED OPIOID AGONIST TREATMENT IN AUSTRALIA: THE ETHOS ENGAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Artenie AA; Cunningham E; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Applegate TL; Dillon JF; Fraser C; Gane E; Litwin AH; Marks P; Matthews GV; Quiene S; Thurnheer MC; Weltman M; Dore G; Bruneau J; Grebely J, 2018, 'Drug and alcohol use patterns during and following treatment with sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use: Insights from trajectory analyses', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, pp. 31 - 32, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Callander D; Read P; Minichiello V; Hamilton R; Chow EPF; Ali H; Lewis D; Hellard M; Donovan B, 2015, 'HIV AND STIS AMONG MALE SEX WORKERS ATTENDING AUSTRALIAN SEXUAL HEALTH CLINICS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A207 - A208, http://dx.doi.org/10.1136/sextrans-2015-052270.537
2015
Gilliver R; Scholey K; Chronister K; van Beek I; Read P, 2015, 'TARGETED PRIMARY HEALTH CARE AND SEXUAL HEALTH SERVICES CAN DELIVER THE HEPATITIS C STRATEGY: ONE YEAR OF FIBROSCANS AT THE KIRKETON ROAD CENTRE (KRC)', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A193 - A194, http://dx.doi.org/10.1136/sextrans-2015-052270.501
2015
Read P; Tagg K; Jeoffreys N; Gilbert G; Guy R; Donovan B, 2015, 'TREPONEMA PALLIDUM STRAIN-TYPES IN AUSTRALIA AND ASSOCIATION WITH MACROLIDE RESISTANCE', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A36 - A36, http://dx.doi.org/10.1136/sextrans-2015-052270.107
2015
Read PJ; Wand H; Guy R; McNulty A; Donovan B, 2011, 'UNPROTECTED FELLATIO AND PHARYNGEAL GONORRHOEA IN SYDNEY SEX WORKERS', in SEXUALLY TRANSMITTED INFECTIONS, B M J PUBLISHING GROUP, pp. A130 - A131, http://dx.doi.org/10.1136/sextrans-2011-050108.76
2011
Molloy K; Cho L; Silins E; Read P, 2022, 'Providing unplanned pregnancy care and Early Medical Abortion to marginalised groups at the Kirketon Road Centre (KRC) - a walk in targeted primary health care service in Kings Cross, Sydney', in O4 - Providing unplanned pregnancy care and Early Medical Abortion to marginalised groups at the Kirketon Road Centre (KRC) - a walk in targeted primary health care service in Kings Cross, Sydney, presented at Children by Choice, http://dx.doi.org/10.1016/j.wombi.2022.07.010
2022
Carter A; McManus H; Vickers T; Asselin J; Chow E; Chen M; Fairley C; Bourne C; McNulty A; Read P; Ryder N; McCloskey J; Carmody C; Stoove M; Hellard M; Donovan B; Guy R, 2021, 'IDENTIFYING SUBGROUPS AT HIGHER RISK OF INFECTIOUS SYPHILIS IN MAJOR AUSTRALIAN CITIES: ANALYSIS OF NATIONAL SENTINEL SURVEILLANCE DATA 2011-2018', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 97, pp. A166 - A166, http://dx.doi.org/10.1136/sextrans-2021-sti.435
2021
Sutherland R; Steele M; Silins E; Gulliver R; Read P; Peacock A; Barratt MJ; Page RMS; Bruno R; Rodgers C, 2021, 'FEASIBILITY, CONSUMER ACCEPTABILITY AND BEHAVIOURAL OUTCOMES ASSOCIATED WITH TAKE-HOME FENTANYL TEST STRIPS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S140 - S140, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200341&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Gilliver R; Silins E; Read P, 2021, 'SUSTAINING NALOXONE DISTRIBUTION: A RAPID REVIEW FROM A PRIMARY HEALTHCARE SETTING IN KINGS CROSS, SYDNEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S74 - S74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200184&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Keen P; Patel P; McManus H; Duck T; Callander D; Selvey C; Power C; Gray RT; Vickie K; Asselin J; Read P; Johnson K; Bavinton BR; Grulich AE; Guy R, 2020, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men in New South Wales, Australia 2010 to 2018', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 23, pp. 36 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000551988900063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E42 - E42, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30076-3
2019
Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthew G, 2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'Reinfection following successful HCV DAA therapy among people with recent injecting drug use', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E732 - E733, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Cappetta M; Egerton-Smith A; Read P; Gilliver R, 2019, 'CAN A SMOKING CESSATION CLINIC TARGETED TO MARGINALISED CLIENTS IN KINGS CROSS, SYDNEY BE EFFECTIVE?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S35 - S35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Kearley J; Gilliver R; Lothian R; Cunningham EB; Dore GJ; Read P, 2019, 'MAXIMISING ADHERENCE TO DIRECT-ACTING ANTI-VIRALS FOR HEPATITIS C AMONG STREET-BASED AND MARGINALISED CLIENTS USING AN OPIOID AGONIST TREATMENT PROGRAM: THE RESULTS OF DAILY DOSING', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Kearley J; Gilliver R; Lothian R; Dore GJ; Read P, 2019, 'WHEN TREATMENT ACCESS DOES NOT EQUAL TREATMENT INITIATION: AN ANALYSIS OF CLIENTS WHO DO NOT INITIATE DIRECT ACTING ANTIVIRALS FOR HEPATITIS C', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S60 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Yee J; Dore GJ; Hanson J; Iser D; Danta M; Shaw D; Read P; Balcomb A; Post J; Faros J; Montebello M; Collie P; Hallinan R; Cooper L; Marks P; Hajarizadeh B; Matthews GV, 2018, 'High efficacy of HCV therapy following universal DAA access in Australia: the REACH-C cohort', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 54 - 54, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018
2018
Dalgard O; Grebely J; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and Velpatasvir for Hepatitis C Virus Infection in People with Recent Injecting Drug Use (Simplify): An Open-Label, Single-Arm, Phase 4, Multicentre Trial', in HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, PACINI EDITORE, Vol. 20, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440974900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Gilliver R; Chronister KJ; Lothian R; Kearley J; Machin W; Read P, 2018, 'DAILY DOSING OF DIRECT ACTING ANTIVIRALS FROM A PUBLIC OPIOID SUBSTITUTION TREATMENT PROGRAM FOR MARGINALISED CLIENTS IN KINGS CROSS, SYDNEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S32 - S32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Chronister KJ; Salmon AM; Harrod ME; Jauncey M; Read P, 2018, 'PERCEPTIONS OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG PEOPLE WHO INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S22 - S22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Machin W; Gilliver R; Chronister KJ; Stockburger T; Read P, 2018, 'UNDER THE BRIDGE: IMPACT OF NON-MEDICAL PROVISION OF TAKE HOME NALOXONE TO CLIENTS AT HIGH RISK OF OVERDOSE IN COMMUNITY SETTINGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S49 - S50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Lintzeris N; Monds L; Bravo M; Read P; Harrod ME; Nielsen S, 2018, 'FINDINGS OF THE IMPLEMENTATION OF ORTHN (OVERDOSE RESPONSE WITH TAKE HOME NALOXONE) IN NEW SOUTH WALES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S47 - S47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer CM; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2017, 'Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S513 - S513, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000401056601271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin AH; Dillon JF; Read P; Gane ED; Dore GJ, 2017, 'EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN PEOPLE WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT INJECTING DRUG USE: THE SIMPLIFY STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Grebely J; Marshall AD; Krahe M; Erratt A; Telenta J; Treloar C; Jones SC; Adey S; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop AJ; Applegate TL; Lamoury F; Mowat Y; Jauncey M; Read P; Gilliver R; Smith J; Collie T; Dore GJ, 2016, 'A LIVER HEALTH PROMOTION INTERVENTION INTEGRATING NON-INVASIVE LIVER DISEASE SCREENING IN DRUG AND ALCOHOL SETTINGS: THE LIVERLIFE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 40 - 40
2016
Kearley J; Chronister KJ; Gilliver R; Read P, 2016, 'WHO RETURNS FOR NALOXONE RELENISHMENT? A REAL WORL D ANALYSIS OF CLIENTS RETURNING FOR NALOXONE AT THE KIRKETON ROAD CENTRE IN KINGS CROSS, SYDNEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 45 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Gilliver R; Lothian R; Chronister KJ; Machin W; Kearley J; Read P, 2016, 'THE DOG ATE MY DACLATASVIR: REAL LIFE EXPERIENCES DELIVERING DIRECT ACTING ANTIVIRALS TO MARGINALISED, HOMELESS AND ACTIVE DRUG USERS AT THE KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Kearley J; Gilliver R; Read P; Chronister KJ, 2016, 'INCORPORATING OVERDOSE MANAGEMENT INTO ROUTINE CARE OF PEOPLE WHO INJECT DRUGS WHO ARE UNDERGOING HEPATITIS C TREATMENT WITH DIRECT ACTING ANTIVIRALS AT THE KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Lintzeris N; Monds L; Shanahan M; Harrod M; Nielsen S; Haber PS; Dunlop AJ; Ezard N; Nghi P; Read P; Manzie R; Lenton S; Jauncey M; Trimmingham T; Cairnduff S; Dietze PM, 2016, 'IMPLEMENTING TAKE-HOME NALOXONE INTO ROUTINE CARE IN DRUG AND ALCOHOL TREATMENT SERVICES, NEEDLE SYRINGE PROGRAMS AND PEER OUTREACH SERVICES IN NEW SOUTH WALES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Gilliver R; Scholey K; Van Beek I; Read P, 2015, 'EXPANDING ACCESS TO HEPATITIS CARE AMONG PEOPLE WHO INJECT DRUGS: ONE YEAR OF FIBROSCANS AT THE KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 34, pp. 28 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Chronister KJ; Tayler P; Read P; Van Beek I, 2015, 'EVALUATING A TARGETED APPROACH TO PERFORMANCE AND IMAGE ENHANCING DRUGS INJECTORS' NEEDLE SYRINGE PROGRAM ACCESS AT KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 34, pp. 20 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Sutherland R; Steele M; Silins E; Gilliver R; Read P; Peacock A; Barratt M; Page R; Bruno R; Rodgers C, 2021, 'Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.', presented at APSAD conference, Virtual, 10 November 2021
2021
Chan C; Johnson K; Patel P; Vaughan M; Templeton D; Read P; McNulty A; El-Hayek C; Bavinton B, 2020, 'Community-Based HIV/STI Testing Is Effective at Reaching Priority Populations in New South Wales: An Evaluation of a[TEST]', presented at Joint Australasian Sexual Health & HIV/AIDS Conferences, Virtual, 16 November 2020 - 20 November 2020
2020
McManus H; O'Connor CC; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law M, 2011, 'Examination of Long Term Survival in HIV positive patients with up to 15 years of Antiretroviral Th', presented at AUSTRALASIAN HIV/AIDS CONFERENCE, Canberra, 26 September 2011, https://ashm.blob.core.windows.net/ashmpublic/2011ConferenceHandbook.pdf
2011
Bravo M; Monds L; Mills L; Read P; Harrod ME; Nielsen S; Jauncey M; Rivas C; Malcolm A; Gilliver R; Lintzeris N, 2020, The role of repeat training in participants undertaking take home naloxone interventions, , http://dx.doi.org/10.1101/2020.04.26.20074542
2020
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Rowling D; Doong N; Jackson E; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, Moving Towards HCV Elimination Among People Living with HIV in Australia: Analysis of the CEASE Prospective Cohort Study, , http://dx.doi.org/10.2139/ssrn.3269607
Chan C; Patel P; Johnson K; Vaughan M; Price K; McNulty A; Templeton D; Read P; Cunningham P; Bavinton B, 2020, Evaluation of ACON’s community-based a[TEST] HIV and STI testing services, 2015-2019, http://dx.doi.org/10.26190/5f0ff88e20f47
2020